GSK plc
Health Care
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
439 / 1328
Position in country
882 / 1912
Return on Assets, %
8.9
-2.7
Net income margin, %
4.9
2.8
EBITDA margin, %
12.3
10.8
Debt to Equity, %
134.9
19.2
Intangible assets and goodwill, %
36.5
3.6
Revenue CAGR 3Y, %
7.5
8.5
Total Equity change 1Y, %
32.5
0
Revenue Y, % chg
6.5
0.5
P/E
13.5
22.7
P/BV
4.9
1.5
P/S
2.2
2.3
EV/S
2.6
2.4
EV/EBITDA
8.6
7.4
Average Analyst recommendation
Hold
Hold
Average upside forecasts, %
11.9
51.3
Forward P/E
9.9
15.6
Dividend Yield, %
3.6
1.7
Forward Dividend Yield, %
3.7
0.2
Expected dividend per share
1.5
0
Payout Ratio, %
47.7
30.3
Dividend Ex Date
2024-02-22
Competitors
Ranks
-
Novo Nordisk A/S
00%
-
AstraZeneca PLC
00%
-
Indivior PLC
00%
-
GSK plc
00%
-
Verona Pharma PLC
00%
-
Eli Lilly and Co
00%
-
Hikma Pharmaceuticals PLC
00%
-
Johnson & Johnson
00%
-
Merck & Co Inc
00%
-
Dechra Pharmaceuticals Ltd
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
United Kingdom
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Pharmaceuticals
Sub-sector
Health Care
Capitalization (millions of $)
85492.2
Ticker
GSK.N
ISIN
US37733W2044
IPO date
1972-05-22
Availability on Russian exchanges
No
Reporting for
2024-03-01
Date fact. publication of reports
2023-12-31
Company Description
GlaxoSmithKline PLC is a global healthcare company. The Company researches and develops a range of products in three primary areas: Pharmaceuticals, Vaccines and Consumer Healthcare. Its product formulations include tablets, creams/ointments, inhalers, injections, liquids and sterile products. Its Pharmaceuticals business has a portfolio of established medicines in respiratory, human immunodeficiency virus (HIV), immuno-inflammation and oncology. Its Vaccines business has a portfolio of vaccines to help protect people from a range of diseases throughout their lives. Its vaccines tackle diseases, including pneumococcal disease, meningitis, hepatitis, rotavirus, whooping cough and influenza. Its Consumer Healthcare business combines science and consumer insights to create everyday healthcare brands that consumers trust, and experts recommend for oral health, pain relief, cold, flu and allergy, digestive health and vitamins, minerals and supplements.
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: